George Munson

Prof. George Munson

orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 October 2000 in Journal of Bacteriology
Verified
Journal Article
Open access
PDF file
GMGeorge Munson
George Munson
DLDeborah L. Lam
Deborah L. Lam
FOFranklin W. Outten
Franklin W. Outten
TOThomas V. O'Halloran
Thomas V. O'Halloran
Using a genetic screen we have identified two chromosomal genes, cusRS ( ylcA ybcZ ), from Escherichia coli K-12 that encode a two-component, signal transduction system that is responsive to copper ions. This regulatory system is required for copper-induced expression of pcoE , a plasmid-borne gene from the E. coli copper resistance operon pco . The closest homologs of CusR and CusS are plasmid-borne two-component systems that are also involved in metal responsive gene regulation: PcoR and PcoS from the pco operon of E. coli ; CopR and CopS from the cop operon, which provides copper resistance to Pseudomonas syringae ; and SilR and SilS from the sil locus, which provides silver ion resistance to Salmonella enterica serovar Typhimurium. The genes cusRS are also required for the copper-dependent expression of at least one chromosomal gene, designated cusC ( ylcB ), which is allelic to the recently identified virulence gene ibeB in E. coli K1. The cus locus may comprise a copper ion efflux system, because the expression of cusC is induced by high concentrations of copper ions. Furthermore, the translation products of cusC and additional downstream genes are homologous to known metal ion antiporters.

1 February 2010 in Microbes and Infection
Verified
Journal Article
Closed access
JFJames Michael Fleckenstein
James Michael Fleckenstein
PHPhilip R. Hardwidge
Philip R. Hardwidge
GMGeorge Munson
George Munson
DRDavid A. Rasko
David A. Rasko
HSHalvor Sommerfelt
Halvor Sommerfelt
HSHans Steinsland
Hans Steinsland

24 September 2015 in eLife
Verified
Journal Article
Open access
RMRyan M McCormack
Ryan M McCormack
LALesley R de Armas
Lesley R de Armas
MSMotoaki Shiratsuchi
Motoaki Shiratsuchi
DFDesiree G Fiorentino
Desiree G Fiorentino
MOMelissa L Olsson
Melissa L Olsson
EPEckhard R Podack
Eckhard R Podack
Perforin-2 (MPEG1) is a pore-forming, antibacterial protein with broad-spectrum activity. Perforin-2 is expressed constitutively in phagocytes and inducibly in parenchymal, tissue-forming cells. In vitro, Perforin-2 prevents the intracellular replication and proliferation of bacterial pathogens in these cells. Perforin-2 knockout mice are unable to control the systemic dissemination of methicillin-resistant Staphylococcus aureus (MRSA) or Salmonella typhimurium and perish shortly after epicutaneous or orogastric infection respectively. In contrast, Perforin-2-sufficient littermates clear the infection. Perforin-2 is a transmembrane protein of cytosolic vesicles -derived from multiple organelles- that translocate to and fuse with bacterium containing vesicles. Subsequently, Perforin-2 polymerizes and forms large clusters of 100 Å pores in the bacterial surface with Perforin-2 cleavage products present in bacteria. Perforin-2 is also required for the bactericidal activity of reactive oxygen and nitrogen species and hydrolytic enzymes. Perforin-2 constitutes a novel and apparently essential bactericidal effector molecule of the innate immune system.

31 January 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
TNTao Ni
Tao Ni
FJFang Jiao
Fang Jiao
XYXiulian Yu
Xiulian Yu
SASaša Aden
Saša Aden
LGLucy Ginger
Lucy Ginger
RGRobert J. C. Gilbert
Robert J. C. Gilbert
Bactericidal perforin-2 assembles an inactivated pre-pore complex and undergoes a 180° reconfiguration for membrane attack.

1 November 2011 in Clinical and Vaccine Immunology
Verified
Journal Article
Closed access
PDF file
KRKoushik Roy
Koushik Roy
DHDavid J. Hamilton
David J. Hamilton
GMGeorge Munson
George Munson
JFJames Michael Fleckenstein
James Michael Fleckenstein
Enterotoxigenic Escherichia coli (ETEC) strains are a heterogeneous group of pathogens that produce heat-labile (LT) and/or heat-stable (ST) enterotoxins. Collectively, these pathogens are responsible for hundreds of thousands of deaths annually in developing countries, particularly in children under the age of 5 years. The heterogeneity of previously investigated molecular targets and the lack of complete sustained protection afforded by antitoxin immunity have impeded progress to date toward a broadly protective vaccine. Many pathogens, including ETEC, have the capacity to form outer membrane vesicles (OMV), which often contain one or more virulence proteins. Prompted by recent studies that identified several immunogenic virulence proteins in outer membrane vesicles of ETEC, we sought to examine the immunogenicity and protective efficacy of these structures in a murine model of infection. Here we demonstrate that immunization with OMV impairs ETEC colonization of the small intestine and stimulates antibodies that recognize the heat-labile toxin and two additional putative virulence proteins, the EtpA adhesin and CexE. Similar to earlier studies with EtpA, vaccination with LT alone also inhibited intestinal colonization. Together, these findings suggest that OMV could be exploited to deliver protective antigens relevant to development of ETEC vaccines.